Katarina Sjögreen Gleisner
1 – 10 of 92
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
[177Lu]Lu-DOTA-TATE tumour and organ time-activity curves : prediction from a single-time-point [68Ga]Ga-DOTA-TATE PET/CT measurement
- Contribution to journal › Article
-
Mark
Improved patient models for simulation of clinically realistic 68Ga-SSTR PET and 177Lu-PRRT SPECT studies
(2026) In EJNMMI Physics
- Contribution to journal › Article
-
Mark
Clinical Trials in Molecular Radiotherapy : An Overview of the Landscape
- Contribution to journal › Article
-
Mark
Direct estimation of activity concentration in regional voxels with application to 177Lu peptide receptor radionuclide therapy
- Contribution to journal › Article
-
Mark
Patient Survival and Its Relation to Tumor Absorbed Dose in [177Lu]Lu-DOTATATE Therapy of Neuroendocrine Tumors
(2026) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine
- Contribution to journal › Article
- 2025
-
Mark
Can 177Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
(2025) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 66(7). p.1082-1090
- Contribution to journal › Article
-
Mark
A validation protocol for 177Lu-SPECT image quantification as a basis for multi-centre kidney dosimetry
- Contribution to journal › Article
- 2024
-
Mark
Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE
- Contribution to journal › Article
-
Mark
Implementation of dosimetry for molecular radiotherapy; results from a European survey
- Contribution to journal › Article
-
Mark
The contest between internal and external-beam dosimetry : The Zeno's paradox of Achilles and the tortoise
- Contribution to journal › Scientific review
